In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
Rajguru encourages patients to pair BPC-157 therapy with healthy lifestyle habits, such as proper nutrition, exercise, and stress management, to maximize their results
"Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157." Current Medicinal Chemistry
Jada, we offer unparalleled personalized weight loss solutions
Frequencies range from weekly to monthly, depending on your goals and baseline levels